Achillion Pharmaceuticals
AcquiredAlexion Global Site
- Founded
- 1998
- Business Model
- B2B
- Website
- achillion.com
- Acquisition Date
- Oct 2019
About
Achillion Pharmaceuticals was a biopharmaceutical company that developed treatments for infectious and complement-mediated diseases, including oral small-molecule Factor D inhibitors. Founded in 1998 by Yale scientists, it later focused on rare disorders. Alexion Pharmaceuticals completed its acquisition of Achillion on January 28, 2020, and the former Achillion website now serves the Alexion global site.
Summary
Achillion Pharmaceuticals is a Biotech company, founded in 1998.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2019
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/achillion-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/achillion-pharmaceuticals" alt="Achillion Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>